Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Uprifosbuvir in Healthy and HCV-Infected Subjects
NCT01974687Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of uprifosbuvir in hepatitis C (HCV), sponsored by Merck & Co.. Started Oct 2013; status: completed.
02
Drugs
uprifosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01974687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01974687.